Sonoma Pharmaceuticals (SNOA) Inventory Average (2011 - 2026)

Sonoma Pharmaceuticals' Inventory Average history runs 16 years deep, the most recent figure standing at $3.7 million for Q1 2026.

• On a quarterly basis, Inventory Average rose 15.7% year-over-year to $3.7 million in Q1 2026; TTM through Mar 2026 was $3.7 million, a 15.7% increase from a year earlier, with the FY2026 full-year figure at $3.4 million, up 10.21% from the prior year.
• Inventory Average held at $3.7 million in Q1 2026 per SNOA's latest filing, from $3.7 million in the prior quarter.
• Across five years, Inventory Average topped out at $3.7 million in Q3 2025 and bottomed at $2.6 million in Q3 2023.
• The 5-year median for Inventory Average is $3.0 million (2024), against an average of $3.1 million.
• Across the five-year window, Inventory Average decreased 9.81% in 2023 and grew 23.71% in 2025, its largest moves.
• Year by year, Inventory Average stood at $2.9 million in 2022, then declined by 6.91% to $2.7 million in 2023, then climbed by 14.01% to $3.1 million in 2024, then increased by 17.69% to $3.7 million in 2025, then increased by 0.23% to $3.7 million in 2026.
• Per Business Quant, the three latest SNOA Inventory Average figures stand at $3.7 million (Q1 2026), $3.7 million (Q4 2025), and $3.7 million (Q3 2025).